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ABSTRACT 
Neutrophil extracellular traps (NETs) are web-like structures composed by a chromatin 
backbone, histones and antimicrobial proteins. NETs constitute yet another mechanism 
deployed by neutrophils to immobilise and kill microorganisms, thus contributing to the host 
innate immunity. Neutrophils cast NETs upon stimulation by a variety of stimuli, including 
bacteria, protozoa, fungi, viruses, their products and also host factors like chemokines, 
complement and activated platelets.  
NETs production or NETosis occurs as a result of activation of neutrophil PKC, Raf-MEK-
ERK and NADPH oxydase signalling pathways. Driven mostly by peptidylarginine deiminase 
4 (PAD4) citrullination of histones, the hallmark of NETosis is chromatin decondensation, 
rupture of nuclear membrane and release of nuclear and granular contents into the cytoplasm, 
prior their release into the extracellular space. NETs control propagation of pathogens by 
entrapping them within the lose chromatin web and kills them with the antimicrobial molecules 
–granule proteins and histones- present in high concentrations within the chromatin network.  
Despite contributing to host defence, aberrant NET formation may damage tissues and activate 
inflammatory cells, contributing to several pathologies, including sepsis, systemic 
inflammatory response syndrome, autoimmune diseases and thrombosis. 
This review presents an overview of our current knowledge of NETs physiology and their role 
in fighting and propagating disease.   
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ABSTRACT 
Las trampas extracelulares de neutrófilos (NETs, de su sigla en inglés) son estructuras tipo red, 
compuestas por un esqueleto de cromatina, histonas y proteínas microbicidas. Las NETs 
constituyen un mecanismo más utilizado por los neutrófilos para inmovilizar y eliminar 
microorganismos, contribuyendo de esta manera a la inmunidad innata del huésped. Los 
neutrófilos producen NETs en respuesta a diversos estímulos, que incluyen bacterias, 
protozoos, hongos, virus y productos derivados; además de factores del huésped como 
quimiocinas, complemento y plaquetas activadas. 
La producción de NETs o NETosis ocurre como resultado de la activación en el neutrófilo de 
vías de señalización intracelular dependientes de PKC, Raf-MEK-ERK y NADPH oxidasa. El 
sello distintivo de la NETosis es la decondensación de cromatina, producida principalmente 
por la citrulinación de histonas catalizada por la enzima peptidyl arginine deiminasa 4 (PAD4). 
Este evento es seguido de ruptura de la membrana nuclear y liberación del contenido granular 
del neutrófilo en el citoplasma, seguido de su liberación al medio extracelular. Las NETs 
inmovilizan patógenos atrapándolos en sus redes de cromatina laxa, controlando así su 
diseminación, y los eliminan mediante la actividad microbicida de proteínas granulares e 
histonas, que están presentes en concentraciones elevadas en las redes de cromatina. A pesar 




de contribuir a la defensa del huésped, la formación aberrante de NETs puede ocasionar daño 
tisular y activar células inflamatorias, contribuyendo así a diversas patologías como sepsis, 
síndrome de respuesta inflamatoria sistémica, enfermedades autoinmunes y trombosis. 
Esta revisión presenta un repaso del conocimiento actual sobre la fisiología de las NETs, y su 
papel combatiendo y desencadenando enfermedades.  
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Neutrophils are the most abundant white blood cells, accounting to 60% in normal conditions 
and represent the first line of defence against infection. Neutrophils present two morphological 
hallmarks: their distinctive polymorphic nucleus comprising 3-5 lobules, making the nucleus 
more flexible and allowing neutrophils to extravasate through endothelial gaps to reach sites 
of infection; and the granules, containing acid hydrolases and antimicrobial peptides. Until 
recently, the known strategies as key players of the host innate immune response were two: 1) 
phagocytosis, which involves ensnaring the microorganism in a phagosome and fusion with 
specialised lysosomes with antimicrobial enzymes that kill the microorganism intracellularly; 
and 2) degranulation, process that involves antimicrobial molecules release at sites of infection. 
In 2004 a third strategy was described by Brinkmann et al: the release of neutrophil 
extracellular traps (NETs) [1]. 
NETs comprise a backbone of extracellular DNA associated with histones and granular 
antimicrobial components such as the proteases neutrophil elastase (NE), cathelicidins, 
proteinase 3 and gelatinase; myeloperoxidase (MPO), cathepsin G and lactoferrin [1-3]. 
 
NETs formation 
NETs formation can be briefly described by a sequence of events comprising neutrophil 
stimulation, release of granular contents to the cytoplasm and nucleus; nuclear delobulation 
and nuclear envelope disintegration, chromatin decondensation and finally, cellular membrane 
rupture and NETs release (Figure 1).   
NETs are produced in response to a number of stimuli, such as lipopolysaccharide (LPS), 
cytokines (IL-8) and bacteria, fungi or activated platelets, upon stimulation of their 
correspondent neutrophil receptors, namely Toll-like receptors (TLRs), cytokine receptors and 
Fc receptors [1, 4]. Receptor activation is followed by activation of one or more of signalling 
cascades involving Raf-MEK-ERK pathway activation [5], Ca2+ mobilisation from 
intracellular and extracellular pools [6], PKC activation and assembly of the NADPH oxidase 
complex followed by the generation of reactive oxygen species (ROS). ROS, in turn, act as 
secondary messengers in the process that leads to gradual dissolution of the nuclear membrane 
and the granules, thus facilitating contact of NETs components within the cytoplasm [7]. 
Finally, NETs are released and, in most cases, the neutrophil dies. The term NETosis was 
coined for this type of cell death, to differentiate it from apoptosis and necrosis [8]. Unlike 
apoptosis, NETosis does not exhibit DNA fragmentation not surface exposure of 
phosphatidylserine prior cell death; and chromatin undergoes decondensation instead of 
condensation and nuclear fragmentation typical of apoptosis. NETosis also differs from 
necrosis, which exhibits preserved nuclear membrane and granules.  
 






Figure 1 Schematic representation of the key events leading to NETs formation. MPO: 
myeloperoxidase, NE: neutrophil elastase. 
 
Although several signalling pathways have been described to trigger NETosis, the mechanisms 
appear to be redundant and despite claims, none of the factors involved proved to act as a 
crucial step or bottleneck for NETs production. A critical step is, however, the unfolding of 
chromatin. This reaction consists in histone hypercitrullination and is catalysed by peptidyl-
arginine deiminase 4 (PAD4) [9]. This finding led to the publication of several articles 
highlighting PAD4 activity as a potential target to regulate NET formation. However, the 
central role of histone hipercitrullination by PAD4 in NETosis, although important, is 
controversial [10]. For instance, H3cit deficient mice partially retain the ability to form NETs 
[11] and PAD4 inhibition with Cl-amidine leads in most cases only to partial reduction in NETs 
production. Interestingly, NE has been shown to modify histones by proteolysis and contribute 
to NET formation [12]. 
In addition to the described mechanisms, there is increasing consensus that NET formation 
might be classified into three different categories: 
1. Classical or suicidal NETosis, involves Rac2 and NADPS activation. Rac deficient 
mice are deficient in NET formation [13] and NADPH deficient animals have impaired 
NET production [14] and cell lysis [15] via this mechanism. Under this pathway, NET 
release takes between 1-4 hours.  
2. Vital NETosis, nuclear DNA is released by vesicles and is independent from the 
oxidative burst. This mechanism can occur within 5 min-1 hour [4], faster than suicidal 
NETosis 
3. NETs formed by mitochondrial DNA [16]. 




Various approaches are used to stimulate neutrophils to study NETosis in vitro: phorbol-12-
myristate-13-acetate (PMA, a PKC activator), Ca2+ ionophores, H2O2, IL-8 and LPS are among 
the most commonly used. By using pharmacological manipulation of neutrophils from human 
donors it has been possible to establish the contribution of intracellular pathways in NETs 
production. The exact role of ROS in NETosis is not yet clear, however evidence indicates that 
at physiological concentrations, the membrane permeable H2O2, can initiate NETosis [7] 
whereas dipheneylene iodonium (DPI, a NADPH oxidase inhibitor) [17] and catalase inhibit 
NET formation [7]. Similarly, ionomycin (a Ca2+ ionophore) induces NETosis, whilst chelation 
of extracellular or intracellular Ca2+ with EGTA or BAPTA-AM, respectively, has shown to 
block NETs production [6]. In vitro NETs measurement involves the use of a combination of 
fluorescent markers for extracellular DNA, such as the cell impermeant DNA marker SYTOX 
Green; granular proteins, typically MPO or NE; and histones. The simultaneous presence of 
the three components is preferred in order to fulfil the criteria of NETs definition. The most 
common methods of detection are multichannel fluorescence microscopy (Figure 2) [1] and 
flow cytometry [1]. Flow cytometry is used to measure NETs formed by cells in suspension 
and has the advantage of being faster, analyse a large number of cells and being observer 
independent; whereas fluorescence microscopy can be used on immobilised neutrophils and 




Figure 2 Fluorescence microscopy image of NETs. A. Neutrophil elastase, B. DNA and C. Histones 
H2A-H2B-DNA complexes. Bar: 10m. From Brinkmann V. et al. [Science. 2004 Mar 5; 
303(5663):1532-5]. Reprinted with permission from AAAS [1]. 
 
Antimicrobial effects of NETs 
Since their discovery in 2004, there is increasing and undisputed evidence that NETs act by 
entrapping and killing microorganisms. One of the main properties of NETs is that they 
constitute a “sticky” structure to which microorganisms bind to [1, 19-21]. The molecular basis 
of the binding mechanism is not yet understood, but electrostatic interactions between 
positively charged NETs components, mainly histones, and negatively charged surface of 
microorganisms may contribute to the strong physical interaction between NETs and 
microorganisms. Supporting this notion, the expression of a capsule reduces binding and 
protects Streptococcus pneumoniae against NETs [22]. 
Once immobilised, microorganisms are susceptible to the action of antimicrobial enzymes and 
peptides, in an extent and fashion that is unclear and might rely on species susceptibility. 
Interestingly, not only granular proteins, but also histones, a major component of NETs, and 
their cleavage products exhibit antimicrobial activity [23, 24]. 
On one hand, several simple but elegant in vitro experiments have provided data confirming 
bactericidal effect of NETs. NETs associate with S. aureus (gram positive bacteria) and 




Salmonella typhimurium and Shigella flexneri (gram negative bacteria) [1]. This association 
makes bacterial virulence factors, such as IpaB from S. flexneri or -toxin from S. aureus, 
susceptible to neutrophil proteases like NE; in agreement with the concept that NETs can act 
by ‘disarming’ pathogens [1]. Furthermore, activated human neutrophils, in the presence of 10 
mol/L cytochalasin D (to block phagocytosis) significantly decreases S. aureus and S. flexneri 
growth by approximately 30%; confirming the bactericidal role of NETs [1, 25]. The 
underlying mechanism for the ability of neutrophils to kill bacteria comprises the bactericidal 
permeability increasing protein (BPI) and histones [1]. Histones and derived peptides haven 
been long shown to kill bacteria [23] with high efficacy, at concentrations as low as 2g/ml 
[1]. 
On the other hand, in vivo evidence shows that NETs found in tissues such as lungs and skin 
contribute to confine bacterial infection in animal models of cellulitis, necrotising fasciitis and 
pneumonia [11, 19, 20]. Moreover, in vivo imaging experiments employing multichannel 
spinning-disk microscopy on murine models of LPS (endotoxemia) or Escherichia coli induced 
sepsis showed that NETs are formed in the microcirculation of highly vascular organs such as 
the liver, surmounting the shear forces of the flowing blood [26]. In endotoxemic mice injected 
with fluorescently labelled E. coli, the formation of vascular NETs resulted in a 4-fold increase 
in the ability to ensnare bacteria from the bloodstream compared with untreated mice [26]. An 
interesting work from Yipp et al. [27] studying Gram-positive skin infections in mice and 
humans in vivo by spinning-disk confocal intravital microscopy, showed that upon S. aureus 
and S. pyogenes infection, neutrophils released NETs without cell lysis. In these models, the 
authors found that neutrophils were able to multitask: carrying out phagocytosis and rapidly 
NETosis that resulted in limited bacterial dissemination. The presence of anuclear neutrophils 
containing bacteria, indicating that phagocytosis and NET formation can take place separately 
in functional compartments of the neutrophil, so that bacteria is retained intracellularly during 
NETs release. Although loss of nucleus would eventually lead to cell death, enucleation is well 
described in platelets and red blood cells, which survive in blood for long periods, well beyond 
the short half-life of ~8h of terminally differentiated neutrophils. This is in agreement with the 
concept of vital NETosis described by others and suggesting that neutrophil functions do not 
follow an either-or route, but can act simultaneously or in fast sequence.  
A different mechanism is used against fungi, such as Aspergillus nidulans, Aspergillus 
fumigatus and Candida albicans. The Zn2+ chelator calproctectin, a heterodimer of the 
neutrophil cytosolic S100A8 and A9 proteins present in NETs, is a critical component of the 
immune defence against C. albicans and A. nidulans. Patients with chronic granulomatous 
disease (CGD), who present deficient NADPH oxidase activity and are therefore impaired in 
their ability to form NETs, often die of infection with A. nidulans. Reconstituting NADPH 
oxidase by gene therapy rescues NETosis capacity and reduces fungal load in these patients 
[28].  
Likewise, several protozoan parasites and viruses induce NETs. NETosis has been shown upon 
infection with parasites such as Leishmania amazonensis and Toxoplasma gondii in which 
pathogen viability is hampered by NETs. Immobilisation of viruses followed by destruction by 
MPO and -defensin is one mechanism employed by NETs during the course of viral infections 
like influenza and HIV [29]. Hence, NETs facilitate the availability of specialised sets of 
proteins involved in bacterial, fungal and viral immunity. 
 
Bacterial mechanisms of evasion 
While the formation of NETs and their role in host defence were unknown to the scientific 
community until 2004, several bacterial properties or functions were described before they 
could be identified as mechanisms of evasion from the action of NETs. Microorganisms 
express numerous virulence factors to surpass the host’s defence mechanisms, produce 




bacterial nutrients from host’s tissue digestion and simultaneously increase invasive potential. 
It is widely known that the most virulent bacteria express a repertoire of digestive enzymes, 
such as proteases, lipases and nucleases. Nucleases production by bacteria such as 
Staphylococcus aureus had been described for a long time [30], yet the specific role of this 
enzyme was poorly understood until the discovery of NETs. Recently, it has been demonstrated 
in relevant animal models of infection, that besides increasing necrotising properties, nucleases 
confer resistance to NET-dependent killing, enhancing the virulence of Gram-negative bacteria 
like S. aureus [25], group A Streptococcus [19] and Streptococcus pneumonia [20]; indicating 
that bacteria entrapment by NETs is critical for their subsequent bactericidal action. DNAse 
production and escape from NETs have also been described in Gram-negative bacteria such as 
Neisseria gonorrhoeae, Vibrio cholera, Yersinia enterocolitica and Aeromonas hydrophila 
[15], 
Besides NETs’ backbone digestion, other mechanisms of evasion are used by microorganisms 
to prevent or escape the action of NETs. The Group A Streptococcus (GAS) produces a 
protease, SpyCEP that cleaves IL-8, decreasing both IL-8-dependent neutrophil endothelial 
transmigration and bacterial killing by reducing NETs formation [31]. GAS also expresses M1, 
a fibrillar protein that coats the surface of all clinical isolates and conferes resistance to the 
antimicrobial action of cathelicidin LL-37, a granular NET component [32]. Haemophilus 
influenzae produces a lipooligosaccharide and DNA based biofilm that confers resistance to 
the antimicrobial effects of NETs components [33].  
 
NETs and tissue injury 
Besides their contribution to innate immunity in host defence, NETs have been also shown to 
trigger collateral tissue damage and therefore to participate in the pathological mechanisms of 
several diseases. NETs induced by sterile inflammation induce thrombosis by providing a 
platform for the coagulation process [34]. It has been shown that histone citrullination by PAD4 
is involved in the development of deep vein thrombosis and that both PAD4-/- or PAD4 
inhibition with Cl-amidine reduce thrombosis in mice [35]. In acute myocardial ischemia, high 
levels of circulating cell-free deoxyribonucleic acid (cf-DNA), a NETs marker, have been 
linked to infarct size [36]. In this case, local myocardial cytokine upregulation induce NETs 
that promote cardiac micro thrombus and endothelial injury, contributing to myocardial no-
reflow [37]. Implementation of a DNase I-based reperfusion treatment strategy attenuates 
experimental myocardial I/R injury [37]. NETs have been also implicated in autoimmune 
diseases such as systemic lupus erythematosus (SLE). Anomalous NET formation may be 
involved in the development of autoimmune responses in predisposed individuals, in 
agreement with the observation that manifestations of autoimmune responses often follow 
microbial infections. SLE affects various organs and is characterized by autoantibodies against 
DNA, chromatin, and DNA-associated proteins, such as NET components. NETs formation 
promotes autoantibody formation in SLE, and the presence of these antibodies protects 
degradation of NETs by nucleases and proteases [38], generating an imbalance between NETs 
formation and clearance that makes SLE patients more susceptible to NETs-induced tissue 
injury [38]. In sepsis, NETs promote progression towards disseminated intravascular 
coagulation and septic shock [2, 4]. In addition, liver damage was described 24 hours after the 
onset of E. coli induced sepsis in mice, evidenced by a significant increase of serum levels of 
alanine aminotransferase compared to non-septic controls [26]. Intravenous infusion of DNAse 
prevented NETs-induced hepatic injury [26]. Importantly, DNAse treatment improves outcome 
in sepsis only when it is delayed, so as not to interfere with the physiological role of NETs in 
targeting the infection [39].  
Histone levels in septic patients correlate with episodes of organ failure, and are significantly 
associated with mortality rates in patients with sepsis [40]. There is also an inverse correlation 




between plasma histones and endogenous activated protein C levels (APC), a plasma protease 
that degrades NETs [40]. Interestingly, administration of APC prevented mortality induced by 
histone injection in mice [41].  
The cytotoxic mechanism of histones involves direct endothelial cell death upon binding to 
endothelial cell plasma membrane based on positive protein charge [42], although further 
studies are needed to elucidate their role in disrupting the endothelial barrier. Together, these 
studies indicate that NETs contribute to disease development and host tissue injury, and 
highlight the importance of a balanced NETosis-NETs clearance. The disturbances attributed 
to NETs described above appear to have a common origin in vascular dysfunction, be it 
disruption of blood flow by accumulation of platelets and red blood cells trapped into the 
DNA/protein mesh or endothelial injury followed by oedema. In both cases, the final 
consequence is impaired tissue oxygenation, cell death and organ failure.    
 
Conclusions 
NETs play a critical role in innate immunity; however enhanced or prolonged NETs formation 
or impaired NETs clearance can lead to disease development and progression. More studies 
are needed to unveil the mechanisms of this recently discovered tool of the immune system in 
health and disease. The study of NETs pathophysiology constitutes a fascinating field in 
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